[EMPLOYMENTREEMENTreement Executivempany This EMPLOYMENTREEMENT (this WHEREAS, thempany desires to employ Executive its Chief Financial Officer on the terms andnditions set forth hereinafter, and Executive desires to be so employed; NOW, THEREFORE, INNSIDERATION of the foregoing facts, the mutualvenants andreementsntained herein and other good and valuablensideration, the parties herebyree follows:] [SERVICESREEMENT 16 This SERVICESREEMENT (thisreement),ted of April RECITALS: B.The Parties have previously entered into anreement setting forth the terms for the services of thensultant the Representative through March 31, 2010. C.At the request of thempany, thensultant hasntinued to provide services to thempany the Representative since April 1, 2010, and the Parties now desire to memorialize] [SKYSTAR BIO-PHARMACEUTICALMPANY RESTRICTED STOCK AWARDREEMENT This Restricted Stock Awardreementreementmpany Grantee Innsideration of thevenants herein set forth, the parties heretoree follows: Stock Award Information. 1. (a)te of Award: April 16, 2010 (b) Grantee: R.ott Cramer (c) Number of Shares: 10,000 (d)] [SKYSTAR APPOINTS NEW CHIEF FINANCIAL OFFICER Michael H. Lan to Become Permanent CFO XI'AN, CHINA April 19, 2010 -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), Mr. Lan hasvanced knowledge of U.S. GAAP and financial reporting requirements and has held internal financialntrol and audit positions with Silganntainersrporation and Gileadiences.Immediately prior to joiningystar, Mr. Lan was founder]

[FORM 10-K  For the fiscal year ended December 31, 2009 OR  For the transition period from ________________ to ________________ 001-15643 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 33-0901534 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China N/A (Zip Code) (8629) 8819-3188 Title of] [SERVICES AGREEMENT This SERVICES AGREEMENT (this “Agreement”), dated as of March 30, 2010, by and between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and R. Scott Cramer, an individual, whose address is 1012 Lewis Drive Winter Park, Florida 32789-2225 (“Consultant”). The Company and the Consultant are collectively referred to herein as the “Parties.” RECITALS: A. B. NOW, THEREFORE, in] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer March 31, 2010 EX-32.1 9 v179475_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer March 31, 2010 EX-32.2 10 v179475_ex32-2.htm] [Contract Registration No. 20096101021102 Technical Cooperation Agreement Name of Project: Cooperative Research of Party A: Xian Tianxing Bio-Pharmaceutical Co., Ltd. (stamp) Party B: Fourth Military Medical University (stamp) China Place of Execution: Xi’an, Shaanxi Province, China Date of Effective: September 23, 2009 Term of Validity: From September 23, 2009 to the date when the performances under the terms of the]

[FORM 10-K For the fiscal year ended December 31, 2009 OR For the transition period from ________________ to ________________ 001-15643YSTAR BIO-PHARMACEUTICALMPANY Nevada 33-0901534 (State or other jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China] [SERVICESREEMENT This SERVICESREEMENT (thisreement),ted of March 30, 2010, by and betweenystar Bio-Pharmaceuticalmpany, a Nevadarporation (thempany), and R.ott Cramer, an individual, whosedress is 1012 Lewis Drive Winter Park, Florida 32789-2225 (Consultant). Thempany and thensultant arellectively referred to herein the Parties.] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this annual report on Form 10-K ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer March 31, 2010] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer March 31, 2010] [Contract Registration No. 20096101021102 Technicaloperationreement Name of Project:operative Research of Party A: Xian Tianxing Bio-Pharmaceutical (stamp) Party B: Fourth Military Medical University (stamp) China Place of Execution: Xian, Shaanxi Province, Chinate of Effective: September 23, 2009 Term of Validity: From September 23, 2009 to thete when the performances under the terms of thereement aremplete.]

[EX-99.1 2 v177693_ex99-1.htm]

[v177693_ex99-1.htm 2 EX-99.1]